“Surgery Following Induction (Neoadjuvant) Therapy With Pembrolizumab in Lung Adenocarcinoma With High PD-L1 Expression”. Respirar 17, no. 1 (October 10, 2025): 68–75. Accessed August 25, 2026. https://respirar.alatorax.org/index.php/respirar/article/view/268.